Pacira BioSciences' Research & Development rose 3591.92% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year increase of 3404.33%. This contributed to the annual value of $81.6 million for FY2024, which is 697.64% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Research & Development is $26.0 million, which was up 3591.92% from $28.2 million recorded in Q2 2025.
Pacira BioSciences' 5-year Research & Development high stood at $28.2 million for Q2 2025, and its period low was $11.6 million during Q3 2021.
Moreover, its 5-year median value for Research & Development was $19.4 million (2022), whereas its average is $19.9 million.
In the last 5 years, Pacira BioSciences' Research & Development soared by 10903.52% in 2022 and then tumbled by 2837.68% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Research & Development stood at $15.5 million in 2021, then rose by 12.83% to $17.5 million in 2022, then rose by 11.19% to $19.5 million in 2023, then increased by 22.78% to $23.9 million in 2024, then increased by 8.66% to $26.0 million in 2025.
Its Research & Development was $26.0 million in Q3 2025, compared to $28.2 million in Q2 2025 and $25.3 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value